Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- N/A
A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load
- Status
- COMPLETED
- Phase
- PHASE4
Effectiveness of Protected Environment Rooms for AML and MDS
- Status
- TERMINATED
- Phase
- N/A
Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)
- Status
- COMPLETED
- Phase
- PHASE3
2 Arm Study of Clofarabine IV in MDS Patients
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
- Status
- COMPLETED
- Phase
- PHASE3
Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
- Status
- COMPLETED
- Phase
- PHASE2
Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2